RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. Cash from financing

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 2024-735+130.63%
Dec 31, 2023-319-42.33%
Dec 31, 2022-552-5412.50%
Dec 31, 202110-98.86%
Dec 31, 2020912+8424.30%
Dec 31, 201911-98.49%
Dec 31, 2018710+78.00%
Dec 31, 2017399+4827.16%
Dec 31, 20168-51.79%
Dec 31, 201517-22.94%
Dec 31, 201422+84.75%
Dec 31, 201312+15.69%
Dec 31, 201210-86.25%
Dec 31, 201174

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)